• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估组织性筛查计划对宫颈癌发病率的影响:来自意大利北部的 26 年研究。

Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.

机构信息

Romagna Cancer Registry, Romagna Cancer Institute (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRST, IRCCS), Meldola, Forlì, Italy.

Cancer Prevention Unit, Local Health Authority, Forlì, Italy.

出版信息

Int J Cancer. 2019 Mar 1;144(5):1017-1026. doi: 10.1002/ijc.31806. Epub 2018 Dec 4.

DOI:10.1002/ijc.31806
PMID:30120770
Abstract

The impact of the organised cervical cancer (CC) screening programmes implemented in Europe since the 1990s has been insufficiently evaluated. We investigated the changes in CC incidence following the introduction of a screening programme in the Emilia-Romagna Region (northern Italy). The study period was 1988-2013. The programme, targeting women aged 25-64 years (1,219,000 in 2018), started in 1998. The annual incidence rates that would be expected in 1998-2013 in the absence of screening were estimated, first, by analysing the annual rates in 1988-1997 with a log-linear model and, second, by analysing the annual rates in 1988-2013 with an age-period model in which the period effect was enforced to be linear. Cervical adenocarcinoma incidence trend over the entire period was used to validate both estimates. Observed annual rates were compared to the two series of expected ones with the incidence rate ratio (IRR). Incidence remained stable during 1988-1997, peaked in 1998 and then decreased until 2007, when it stabilised. The two series of expected rates were virtually coincident and their trends roughly paralleled the stable adenocarcinoma incidence trend. After 2007, the median IRR was 0.60 (95% confidence interval, 0.45-0.81) based on the log-linear model and 0.58 (95% confidence interval, 0.34-0.97) based on the age-period model. Thirty-six to seventy-five CC cases were prevented annually for an average annual frequency of 6.5 per 100,000 women in the target population. In summary, consistent circumstantial evidences were obtained that the organised screening programme brought about a 40% reduction in annual CC incidence after 10 years.

摘要

自 20 世纪 90 年代以来,欧洲开展的有组织宫颈癌(CC)筛查计划的效果评估不足。我们调查了在艾米利亚-罗马涅地区(意大利北部)引入筛查计划后 CC 发病率的变化。研究期间为 1988-2013 年。该计划针对 25-64 岁的女性(2018 年为 121.9 万人),于 1998 年启动。首先,我们通过对数线性模型分析 1988-1997 年的年度发病率,其次,我们通过在年龄-时期模型中分析 1988-2013 年的年度发病率,在该模型中,时期效应被强制为线性,来估计 1998-2013 年没有筛查的情况下预期的年发病率。整个期间宫颈腺癌发病率的趋势被用来验证这两种估计。将观察到的年度发病率与两个预期系列的发病率进行比较,以得到发病率比值(IRR)。1988-1997 年期间发病率保持稳定,在 1998 年达到峰值,然后在 2007 年下降,之后趋于稳定。两个预期系列的预期率非常接近,其趋势大致与稳定的腺癌发病率趋势平行。2007 年后,基于对数线性模型的中位数 IRR 为 0.60(95%置信区间,0.45-0.81),基于年龄-时期模型的中位数 IRR 为 0.58(95%置信区间,0.34-0.97)。平均每年有 6.5 例 CC 病例被预防,目标人群中每 10 万人中有 36-75 例。总之,我们获得了一致的间接证据,表明有组织的筛查计划在 10 年后使 CC 的年发病率降低了 40%。

相似文献

1
Estimating the impact of an organised screening programme on cervical cancer incidence: A 26-year study from northern Italy.评估组织性筛查计划对宫颈癌发病率的影响:来自意大利北部的 26 年研究。
Int J Cancer. 2019 Mar 1;144(5):1017-1026. doi: 10.1002/ijc.31806. Epub 2018 Dec 4.
2
Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.1985 - 2000年期间,尽管开展了广泛的筛查计划,但意大利中部宫颈腺癌发病率仍呈上升趋势。
Cancer Detect Prev. 2004;28(6):461-4. doi: 10.1016/j.cdp.2004.07.007.
3
Trends in cervical cancer incidence and mortality in Poland: is there an impact of the introduction of the organised screening?波兰宫颈癌发病率和死亡率的趋势:有组织筛查的引入是否有影响?
Eur J Epidemiol. 2017 Jun;32(6):529-532. doi: 10.1007/s10654-017-0291-6. Epub 2017 Aug 5.
4
Changes in the incidence of cervical tumours by disease stage in a cytology-based screening programme.细胞学筛查项目中宫颈肿瘤疾病分期发病率的变化。
J Med Screen. 2020 Jun;27(2):96-104. doi: 10.1177/0969141319885989. Epub 2019 Nov 5.
5
The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.波兰有组织的宫颈癌筛查计划的实施:对欧洲指南依从性的分析。
BMC Cancer. 2015 Apr 14;15:279. doi: 10.1186/s12885-015-1242-9.
6
Immigration, screening, and cervical cancer incidence: an application of Age-Period-Cohort analysis.移民、筛查与宫颈癌发病率:年龄-时期-队列分析的应用。
Eur J Cancer Prev. 2019 Nov;28(6):529-536. doi: 10.1097/CEJ.0000000000000495.
7
Evaluation of the National Cervical Cancer Screening Programme in Singapore.新加坡国家宫颈癌筛查计划评估。
Singapore Med J. 2013 Feb;54(2):96-101. doi: 10.11622/smedj.2013032.
8
Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.北欧国家癌症筛查对截至2017年的死亡、成本和生活质量的影响。
Acta Oncol. 1997;36 Suppl 9:1-60.
9
[Extension of the target age range of mammography screening programme and governance of mammography practice in the Emilia-Romagna Region (Northern Italy)].[艾米利亚-罗马涅地区(意大利北部)乳腺钼靶筛查项目目标年龄范围的扩大及乳腺钼靶检查实践的管理]
Epidemiol Prev. 2017 Jan-Feb;41(1):38-45. doi: 10.19191/EP17.1.P038.010.
10
[The diffusion of screening programmes in Italy, year 2010].[2010年意大利筛查项目的推广情况]
Epidemiol Prev. 2012 Nov-Dec;36(6 Suppl 1):3-7.

引用本文的文献

1
Socioeconomic disparities in HPV vaccine uptake: multivariable analysis of vaccination data from Tianjin (2018-2023).人乳头瘤病毒疫苗接种中的社会经济差异:来自天津(2018 - 2023年)疫苗接种数据的多变量分析
Front Public Health. 2025 Feb 27;13:1428267. doi: 10.3389/fpubh.2025.1428267. eCollection 2025.
2
Effectiveness of high-risk human papillomavirus genotyping for cervical cancer screening. A multicentre screening cohort study in rural China.高危型人乳头瘤病毒基因分型用于宫颈癌筛查的效果。中国农村多中心筛查队列研究。
An Sist Sanit Navar. 2024 May 31;47(2):e1065. doi: 10.23938/ASSN.1065.
3
Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
女性子宫癌和卵巢癌存活后的治愈指标:基于人群的研究。
Am J Epidemiol. 2024 Sep 3;193(9):1224-1232. doi: 10.1093/aje/kwae044.
4
Cervical cancer screening pathways in France in 2015-2021, a nationwide study based on medico-administrative data.2015 - 2021年法国宫颈癌筛查途径:一项基于医疗行政数据的全国性研究
Prev Med Rep. 2023 Sep 28;36:102429. doi: 10.1016/j.pmedr.2023.102429. eCollection 2023 Dec.
5
Clinical Epidemiology of Microinvasive Cervical Carcinoma in an Italian Population Targeted by a Screening Programme.一项筛查项目针对的意大利人群中微侵袭性宫颈癌的临床流行病学
Cancers (Basel). 2022 Apr 22;14(9):2093. doi: 10.3390/cancers14092093.
6
How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study.粪便免疫化学试验筛查项目如何改变年度结直肠癌发病率:一项意大利意向筛查研究。
Br J Cancer. 2022 Aug;127(3):541-548. doi: 10.1038/s41416-022-01813-7. Epub 2022 Apr 20.
7
Five-year annual incidence and clinico-molecular features of breast cancer after the last negative screening mammography at age 68-69.68 - 69岁最后一次乳腺钼靶筛查结果为阴性后的乳腺癌五年年发病率及临床分子特征
Eur Radiol. 2022 Feb;32(2):834-841. doi: 10.1007/s00330-021-08129-9. Epub 2021 Aug 6.
8
The Relationship between Perceived Self-Efficacy and Cervical Cancer Screening among Village Health Volunteers in Suratthani Province, Thailand.泰国素叻他尼省乡村卫生志愿者感知自我效能与宫颈癌筛查的关系。
Asian Pac J Cancer Prev. 2021 Jan 1;22(1):179-183. doi: 10.31557/APJCP.2021.22.1.179.
9
Current Status and Future Perspectives of Molecular Prevention Strategies for Cervical Cancers.宫颈癌分子预防策略的现状与未来展望
Indian J Surg Oncol. 2020 Dec;11(4):752-761. doi: 10.1007/s13193-019-00910-z. Epub 2019 Mar 18.
10
A nationally quasi-experimental study to assess the impact of partial organized breast and cervical cancer screening programme on participation and inequalities.一项全国性的准实验研究,旨在评估部分组织化乳腺癌和宫颈癌筛查计划对参与和不平等的影响。
BMC Cancer. 2020 Dec 4;20(1):1191. doi: 10.1186/s12885-020-07686-4.